However, you need to do their quiz to understand their pricing and to learn more about their health program
Both are legitimate, but patients should understand the sourcing difference
According to FDA prescribing information, nausea occurs in 17-25% of patients taking Mounjaro and 24-31% with Zepbound, constipation in 10-17% (Mounjaro) and 16-24% (Zepbound), and diarrhea in 12-17% (Mounjaro) and 18-23% (Zepbound), with incidence varying by dose
In addition, Kendall found it a little thick, and suggested diluting it with extra water or adding ice
Further research is warranted to elucidate the full therapeutic potential of GLP-1 RAs in AS but like many genetic kidney diseases, Alport syndrome patients have been excluded from important clinical trials exploring therapeutics that slow the progression of CKD